Home/Filings/4/0001493152-23-032280
4//SEC Filing

BUCHAN MELISSA JANE 4

Accession 0001493152-23-032280

CIK 0001873835other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 5:18 PM ET

Size

5.0 KB

Accession

0001493152-23-032280

Insider Transaction Report

Form 4
Period: 2023-09-07
Transactions
  • Purchase

    Common Stock

    2023-09-07$2.46/sh+20,000$49,22620,000 total
Footnotes (1)
  • [F1]This figure is the weighted average sales price of multiple trades ranging from $2.39 to $2.49 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request.

Documents

1 file

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1
  • filerCIK 0001342502

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 5:18 PM ET
Size
5.0 KB